mBio (Oct 2021)

Technology Advances, High-Risk Research, and a Safe Way Forward

  • David R. Franz,
  • James W. Le Duc

DOI
https://doi.org/10.1128/mBio.02373-21
Journal volume & issue
Vol. 12, no. 5

Abstract

Read online

The human and economic toll of the coronavirus disease 2019 (COVID-19) pandemic and the unknowns regarding the origins of the virus, with a backdrop of enormous advances in technologies and human understanding of molecular virology, have raised global concerns about the safety of the legitimate infectious disease research enterprise. We acknowledge the safety and security risks resulting from the broad availability of tools and knowledge, tools and knowledge that can be exploited equally for good or harm.